Next, to explore the role of NAMPT-Exo in aortic stenosis, we administered three doses of NAMPT-Exo to 6-week-old EC CXCR4 KO AS mice, along with PBS control and MSC-Exo, in different groups once a week (Figure 3A). This evidence concerns the gene CXCR4 and aortic valve stenosis.